Complications for minimally invasive lateral interbody arthrodesis: a systematic review and meta-analysis comparing prepsoas and transpsoas approaches
OBJECTIVE Minimally invasive anterolateral retroperitoneal approaches for lumbar interbody
arthrodesis have distinct advantages attractive to spine surgeons. Prepsoas or transpsoas …
arthrodesis have distinct advantages attractive to spine surgeons. Prepsoas or transpsoas …
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
…, C Jackson, S Koyama, F Loebel, X Cui, SH Farber… - Nature medicine, 2018 - nature.com
T cell dysfunction contributes to tumor immune escape in patients with cancer and is
particularly severe amidst glioblastoma (GBM). Among other defects, T cell lymphopenia is …
particularly severe amidst glioblastoma (GBM). Among other defects, T cell lymphopenia is …
T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma
…, SH Farber, AA Elsamadicy, X Cui, S Koyama… - Clinical Cancer …, 2018 - AACR
Purpose: T-cell dysfunction is a hallmark of glioblastoma (GBM). Although anergy and
tolerance have been well characterized, T-cell exhaustion remains relatively unexplored. …
tolerance have been well characterized, T-cell exhaustion remains relatively unexplored. …
Accuracy of free-hand pedicle screws in the thoracic and lumbar spine: analysis of 6816 consecutive screws
BACKGROUND: Pedicle screws are used to stabilize all 3 columns of the spine, but can be
technically demanding to place. Although intraoperative fluoroscopy and stereotactic-guided …
technically demanding to place. Although intraoperative fluoroscopy and stereotactic-guided …
Emerging immunotherapies for glioblastoma
…, CM Suryadevara, KA Batich, SH Farber… - Expert opinion on …, 2016 - Taylor & Francis
Introduction: Immunotherapy for brain cancer has evolved dramatically over the past decade,
owed in part to our improved understanding of how the immune system interacts with …
owed in part to our improved understanding of how the immune system interacts with …
Prospect of rindopepimut in the treatment of glioblastoma
…, R Desai, K Woroniecka, SH Farber… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Rindopepimut (CDX-110) is a peptide vaccine that targets epidermal growth
factor receptor variant III (EGFRvIII), a tumor-specific epitope expressed in the most common …
factor receptor variant III (EGFRvIII), a tumor-specific epitope expressed in the most common …
Ability of electromyographic monitoring to determine the presence of malpositioned pedicle screws in the lumbosacral spine: analysis of 2450 consecutively placed …
Object Pedicle screws provide efficient stabilization along all 3 columns of the spine, but
they can be technically demanding to place, with malposition rates ranging from 5% to 10%. …
they can be technically demanding to place, with malposition rates ranging from 5% to 10%. …
The incidence of spinal cord injury in implantation of percutaneous and paddle electrodes for spinal cord stimulation
FW Petraglia III, SH Farber, R Gramer, T Verla… - … : Technology at the …, 2016 - Elsevier
Objective Spinal cord stimulation (SCS) has been proven effective for multiple chronic pain
syndromes. Over the past 40 years of use, the complication rates of SCS have been well …
syndromes. Over the past 40 years of use, the complication rates of SCS have been well …
[HTML][HTML] Long-term cost utility of spinal cord stimulation in patients with failed back surgery syndrome
SH Farber, JL Han, AA Elsamadicy, Q Hussaini… - Pain …, 2017 - ncbi.nlm.nih.gov
Background: Failed back surgery syndrome (FBSS) is a cause of significant morbidity for up
to 40% of patients following spine surgery, and is estimated to cost almost $20 billion. …
to 40% of patients following spine surgery, and is estimated to cost almost $20 billion. …
Preventing Lck activation in CAR T cells confers Treg resistance but requires 4-1BB signaling for them to persist and treat solid tumors in nonlymphodepleted hosts
Purpose: Chimeric antigen receptor (CAR) T cells have shown promise against solid tumors,
but their efficacy has been limited, due in part, to immunosuppression by CD4 + FoxP3 + …
but their efficacy has been limited, due in part, to immunosuppression by CD4 + FoxP3 + …